DRKS00032073已完成不适用
Radioembolization with holmium-containing microspheres: Use of the Holmium Platform for the treatment of patients with hepatocellular carcinoma
niversitätsklinikum Jena, Klinik für Nuklearmedizin0 个研究点目标入组 27 人开始时间: 2023年6月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Radioembolization treatment using the Holmium Platform (QuiremScout, Q-Suite, QuiremSpheres)
排除标准
- 未提供
研究者
相似试验
已完成
不适用
HOlmium radioembolization as adjuvant treatment to Radiofrequency Ablation for Early STage Hepatocellular carcinoma (HORA EST HCC): a dose-finding studyLiver cancerhepatocellular carcinomaNL-OMON50687eids Universitair Medisch Centrum20
已完成
2 期
Radioactive holmium microspheres for the treatment of patients with unresectable liver metastases; a single center, interventional, non-randomized, phase II efficacy (HEPAR II) trial.NL-OMON39704niversitair Medisch Centrum Utrecht48
已完成
不适用
Radioactive holmium microspheres for the treatment of patients with non-resectable liver metastases of mixed origin; a single center, interventional, non-randomized, open label, safety study.liver metastases of mixed origines10019815NL-OMON35649niversitair Medisch Centrum Utrecht24
已完成
不适用
Intratumoral holmium microspheres brachytherapy for patients with pancreatic cancer; a single center, non-randomized, feasibility study in an open surgical setting- the SLOTH1 studyPancreatic cancerNL-OMON49772Radboud Universitair Medisch Centrum6
招募中
不适用
Percutaneous intratumoural holmium microspheres brachytherapy for patients with pancreatic cancer; a single centre, prospective safety and feasibility studyPancreatic cancerpancreatic adenocarcinoma100179901001471310017998NL-OMON51321Radboud Universitair Medisch Centrum6